CONTEXT: Data regarding the presence, extent, and reversibility of psychological and cognitive features of primary hyperparathyroidism (PHPT) are conflicting. OBJECTIVE: This study evaluated psychological symptoms and cognitive function in PHPT. DESIGN: This is a case-control study in which symptoms and their improvement 6 months after surgical cure of PHPT were assessed. SETTINGS: The study was conducted in a university hospital metabolic bone disease unit and endocrine surgery practice. PARTICIPANTS: Thirty-nine postmenopausal women with PHPT and 89 postmenopausal controls without PHPT participated in the study. INTERVENTION: Participants with PHPT underwent parathyroidectomy. OUTCOME MEASURES: Measurements used in the study were: Beck Depression Inventory (BDI); State-Trait Anxiety Inventory, Form Y (STAI-Y); North American Adult Reading Test (NAART); Wechsler Memory Scale Logical Memory Test, Russell revision (LM); Buschke Selective Reminding Test (SRT); Rey Visual Design Learning Test (RVDLT); Booklet Category Test, Victoria revision (BCT); Rosen Target Detection Test (RTD); Wechsler Adult Intelligence Scale-Revised Digit Symbol Subtest (DSy); Wechsler Adult Intelligence Scale Digit Span Subtest (DSpan). RESULTS: At baseline, women with PHPT had significantly higher symptom scores for depression and anxiety than controls and worse performance on tests of verbal memory (LM and SRT) and nonverbal abstraction (BCT). Depressive symptoms, nonverbal abstraction, and some aspects of verbal memory (LM) improved after parathyroidectomy to the extent that scores in these domains were no longer different from controls. Baseline differences and postoperative improvement in cognitive measures were independent of anxiety and depressive symptoms and were not linearly associated with serum levels of calcium or PTH. CONCLUSIONS: Mild PHPT is associated with cognitive features affecting verbal memory and nonverbal abstraction that improve after parathyroidectomy.
CONTEXT: Data regarding the presence, extent, and reversibility of psychological and cognitive features of primary hyperparathyroidism (PHPT) are conflicting. OBJECTIVE: This study evaluated psychological symptoms and cognitive function in PHPT. DESIGN: This is a case-control study in which symptoms and their improvement 6 months after surgical cure of PHPT were assessed. SETTINGS: The study was conducted in a university hospital metabolic bone disease unit and endocrine surgery practice. PARTICIPANTS: Thirty-nine postmenopausal women with PHPT and 89 postmenopausal controls without PHPT participated in the study. INTERVENTION: Participants with PHPT underwent parathyroidectomy. OUTCOME MEASURES: Measurements used in the study were: Beck Depression Inventory (BDI); State-Trait Anxiety Inventory, Form Y (STAI-Y); North American Adult Reading Test (NAART); Wechsler Memory Scale Logical Memory Test, Russell revision (LM); Buschke Selective Reminding Test (SRT); Rey Visual Design Learning Test (RVDLT); Booklet Category Test, Victoria revision (BCT); Rosen Target Detection Test (RTD); Wechsler Adult Intelligence Scale-Revised Digit Symbol Subtest (DSy); Wechsler Adult Intelligence Scale Digit Span Subtest (DSpan). RESULTS: At baseline, women with PHPT had significantly higher symptom scores for depression and anxiety than controls and worse performance on tests of verbal memory (LM and SRT) and nonverbal abstraction (BCT). Depressive symptoms, nonverbal abstraction, and some aspects of verbal memory (LM) improved after parathyroidectomy to the extent that scores in these domains were no longer different from controls. Baseline differences and postoperative improvement in cognitive measures were independent of anxiety and depressive symptoms and were not linearly associated with serum levels of calcium or PTH. CONCLUSIONS: Mild PHPT is associated with cognitive features affecting verbal memory and nonverbal abstraction that improve after parathyroidectomy.
Authors: Sanziana A Roman; Julie Ann Sosa; Linda Mayes; Eric Desmond; Leon Boudourakis; Rong Lin; Peter J Snyder; Elizabeth Holt; Robert Udelsman Journal: Surgery Date: 2005-12 Impact factor: 3.982
Authors: Laura H Coker; Kashemi Rorie; Larry Cantley; Kimberly Kirkland; David Stump; Nicole Burbank; Terry Tembreull; Jeff Williamson; Nancy Perrier Journal: Ann Surg Date: 2005-11 Impact factor: 12.969
Authors: Gerhard Prager; Andreas Kalaschek; Klaus Kaczirek; Christian Passler; Christian Scheuba; Gernot Sonneck; Bruno Niederle Journal: Surgery Date: 2002-12 Impact factor: 3.982
Authors: Elizabeth A Mittendorf; Jeffrey S Wefel; Christina A Meyers; David Doherty; Suzanne E Shapiro; Jeffrey E Lee; Douglas B Evans; Nancy D Perrier Journal: Endocr Pract Date: 2007 Jul-Aug Impact factor: 3.443
Authors: Theresia Weber; Monika Keller; Isabella Hense; Alexander Pietsch; Ulf Hinz; Tobias Schilling; Peter Nawroth; Ernst Klar; Markus W Büchler Journal: World J Surg Date: 2007-06 Impact factor: 3.282
Authors: Dominika Babińska; Marcin Barczyński; Tomasz Stefaniak; Tomasz Osęka; Anna Babińska; Dariusz Babiński; Krzysztof Sworczak; Andrzej J Lachiński; Wojciech Nowak; Zbigniew Sledziński Journal: Langenbecks Arch Surg Date: 2011-12-08 Impact factor: 3.445
Authors: G Paslakis; M Gilles; P Frankhauser; O Lanczik; M Deuschle; L Frölich; F H H Müller; D Kopf Journal: J Nutr Health Aging Date: 2010-11 Impact factor: 4.075
Authors: C Marcocci; M L Brandi; A Scillitani; S Corbetta; A Faggiano; L Gianotti; S Migliaccio; S Minisola Journal: J Endocrinol Invest Date: 2015-03-28 Impact factor: 4.256
Authors: A Trombetti; E R Christ; C Henzen; G Gold; M Brändle; F R Herrmann; C Torriani; F Triponez; M Kraenzlin; R Rizzoli; C Meier Journal: J Endocrinol Invest Date: 2016-01-07 Impact factor: 4.256
Authors: Eric R Braverman; Thomas J H Chen; Amanda L C Chen; Vanessa Arcuri; Mallory M Kerner; Anish Bajaj; Javier Carbajal; Dasha Braverman; B William Downs; Kenneth Blum Journal: BMC Endocr Disord Date: 2009-10-13 Impact factor: 2.763